Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock

🤖 Plain-English Summary

BACKGROUND: The effects of temporary mechanical circulatory support with a microaxial flow pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock remains unclear. The incidence of a composite of adverse events was higher with the use of the microaxial flow pump.

🔑 Key Findings

• METHODS: In an international, multicenter, randomized trial, we assigned patients with STEMI and cardiogenic shock to receive a microaxial flow pump (Impella CP) plus standard care or standard care alone.
• The primary end point was death from any cause at 180 days.
• A composite safety end point was severe bleeding, limb ischemia, hemolysis, device failure, or worsening aortic regurgitation.

🔗 Related Resources